Were you affected by investment losses in BBWI securities between June 4, 2024, and November 19, 2025? Affected Investor Losses Summary Bath & Body Works, Inc. securities fraud class action filed Purchasers or acquirers of Bath & Body Works, Inc. (NYSE: BBWI) securities Seeking recovery of investment losses for material misstatements and/or omissions (as alleged) from June 4, 2024 through November 19, 2025 Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) can assist at no cost to investor RADNOR, Pa.

Independent Bank Corp. (INDB) Q4 2025 Earnings Call Transcript

SLB N.V. (SLB) Q4 2025 Earnings Call Transcript

Shares of Energy Transfer (NYSE:ET) rose 4.4% this week, coinciding with a sharp shift in retail investor sentiment on Reddit.

McCormick & Company now trades near its 52-week low and below historical valuation, offering an attractive risk-reward setup. MKC demonstrates resilient volume growth, steady market share gains, and benefits from health-conscious, at-home cooking trends. Despite near-term margin pressures from commodity costs and tariffs, management guides for margin improvement and ongoing efficiency initiatives.

NEW YORK, NY / ACCESS Newswire / January 23, 2026 / Investors encountering SMX (NASDAQ:SMX) for the first time often start with the obvious headline: a dramatic 2025 price move. A rally exceeding 4,000% naturally draws attention, and from a trading perspective, that reaction makes sense.

Shares of Hycroft Mining ( NASDAQ:HYMC ) are trading at $50.27, up 2,236% over the past year, and retail investors are acting like the rally has room to run.

CNBC's Julias Boorstin reports on news regarding TikTok.

Gevo, Inc. (GEVO) Discusses Leadership Transition and Strategic Vision for Future Growth Transcript

Matt Miskin, Manulife John Hancock Investments, joins 'The Exchange' to discuss the investment mistakes to avoid, which are set to benefit from policy this year and much more.

Hercules Capital is rated a buy, supported by robust dividend coverage and record originations as the Fed cuts rates. HTGC maintains a 10% dividend yield, with 104% coverage of the aggregate dividend and 122% coverage of the base dividend. Portfolio growth is strong, with total investments up 17.8% year-to-date, with AUM up 20.7% over its year-ago comp.

PENN Entertainment is rated a cautious buy, with valuation appearing asymmetrical and downside seemingly limited by low P/B and EV multiples. Recent digital strategy missteps, including the failed ESPN partnership and $825 million impairment, have damaged confidence and weighed on results. PENN's core retail casino business remains stable and profitable, generating $1.4 billion in Q3 revenue and 32% EBITDAR margins.

Advanced Micro Devices, Inc. is rated Hold, reflecting strong AI-driven growth but a premium valuation versus peers like Nvidia. Consensus expects AMD to deliver over 50% annual EBITDA growth through 2028, driven by 30% revenue growth and margin expansion. AMD's Data Center segment is the primary growth driver, with over 60% revenue growth projected for 2026 and EBITDA doubling.

SAN DIEGO, CA / ACCESS Newswire / January 23, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company focused on rebalancing inflammation, announced today the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 13,065,000 shares of common stock, issued by the Company on September 11, 2025 (the "Existing Warrants"), at reduced exercise price of $0.86 per share. The shares of common stock issuable upon exercise of the Existing Warrants are registered pursuant to an effective registration statement on Form S-3 (File No.

Tesla said last week that it would stop offering Full Self-Driving as a one-time $8,000 purchase.

Shares of Altimmune ( NASDAQ:ALT ) surged 35.4% over the past week, coinciding with a dramatic shift in retail investor sentiment on Reddit.

Chile's environmental regulator said on Friday it has fined Antofagasta Minerals about $775,000 for failing to comply with water management regulations at its Centinela copper mine.

NEW YORK, Jan. 23, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP is investigating Ultragenyx Pharmaceutical Inc. (Nasdaq: RARE) following the Company's announcement of topline results from its Phase III Orbit and Cosmic Studies, focusing on the effectiveness of setrusumab (UX143) on Osteogenesis Imperfecta. Investors with concerns about Ultragenyx's business operations may click here for more information.

(NASDAQ: LULU) NEW YORK, Jan. 23, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP is investigating lululemon athletica inc. (NASDAQ: LULU) concerning the company's product development processes and supply chain management following a pause on e-commerce sales for the Company's new "Get Low" collection.

Eastern Bankshares, Inc. (EBC) Q4 2025 Earnings Call Transcript